IDEXX Laboratories Inc (IDXX)
488.04
-6.22
(-1.26%)
USD |
NASDAQ |
Apr 25, 14:54
IDEXX Laboratories Cash from Financing (Quarterly): -101.84M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -101.84M |
| September 30, 2023 | -43.04M |
| June 30, 2023 | -151.03M |
| March 31, 2023 | -146.08M |
| December 31, 2022 | -116.72M |
| September 30, 2022 | -148.83M |
| June 30, 2022 | -91.91M |
| March 31, 2022 | -13.48M |
| December 31, 2021 | -165.82M |
| September 30, 2021 | -221.73M |
| June 30, 2021 | -180.22M |
| March 31, 2021 | -129.65M |
| December 31, 2020 | 0.398M |
| September 30, 2020 | -104.18M |
| June 30, 2020 | -161.53M |
| March 31, 2020 | 16.90M |
| December 31, 2019 | -74.39M |
| September 30, 2019 | -99.75M |
| June 30, 2019 | -109.49M |
| March 31, 2019 | -2.781M |
| December 31, 2018 | -117.81M |
| September 30, 2018 | -84.29M |
| June 30, 2018 | -70.71M |
| March 31, 2018 | -324.99M |
| December 31, 2017 | -78.06M |
| Date | Value |
|---|---|
| September 30, 2017 | -67.87M |
| June 30, 2017 | -63.40M |
| March 31, 2017 | 1.313M |
| December 31, 2016 | -77.25M |
| September 30, 2016 | -69.25M |
| June 30, 2016 | -73.14M |
| March 31, 2016 | -2.562M |
| December 31, 2015 | -64.60M |
| September 30, 2015 | -39.66M |
| June 30, 2015 | -33.53M |
| March 31, 2015 | 36.80M |
| December 31, 2014 | 42.34M |
| September 30, 2014 | -76.27M |
| June 30, 2014 | -54.55M |
| March 31, 2014 | -14.96M |
| December 31, 2013 | -33.06M |
| September 30, 2013 | -40.33M |
| June 30, 2013 | -31.32M |
| March 31, 2013 | 2.252M |
| December 31, 2012 | -49.85M |
| September 30, 2012 | -37.23M |
| June 30, 2012 | -31.70M |
| March 31, 2012 | -6.564M |
| December 31, 2011 | 4.01M |
| September 30, 2011 | -36.53M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-221.73M
Minimum
Sep 2021
16.90M
Maximum
Mar 2020
-107.49M
Average
-109.49M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Stryker Corp | -286.00M |
| Haemonetics Corp | 109.43M |
| Align Technology Inc | -350.28M |
| Edwards Lifesciences Corp | -413.20M |
| ACADIA Pharmaceuticals Inc | 5.434M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 249.85M |
| Cash from Investing (Quarterly) | -30.44M |
| Free Cash Flow | 772.88M |
| Free Cash Flow Per Share (Quarterly) | 2.589 |
| Free Cash Flow to Equity (Quarterly) | 288.22M |
| Free Cash Flow to Firm (Quarterly) | 221.87M |
| Free Cash Flow Yield | 1.89% |